Dr. Berglund’s scientific career has revolved around understanding the role of RNA in biology. The focus of his research is in neuromuscular diseases with the goal of translating basic science into therapeutic strategies using a combination of biochemical, cellular, genomic and computational approaches. For the last 16 years at the Universities of Oregon and Florida his research group has focused on RNA splicing with an emphasis on understanding the mechanisms of a common form of muscular dystrophy, myotonic dystrophy, as well as other microsatellite diseases such as amyotrophic lateral sclerosis (ALS), and spinocerebellar ataxias (SCAs).
National Ataxia Foundation Research Grant Awarded to Dr. Hannah Shorrock
Myotonic provides two years of support for Dr. Jana Jenquin’s research on Myotonic Dystrophy Types 1 and 2.
November 21, 2019
Myotonic Dystrophy Foundation (MDF) provides two years of support for Carl’s research on Myotonic Dystrophy Type 1.
Published July 17 2019 in ACS Pharmacology and Translational Science
At the International Myontonic Dystrophy Consortium 12 (IDMC12) meeting, Gothenburg Sweden